(Q33401348)

26 July 2017

Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases (English)

1 reference

macrophage activation syndrome

26 July 2017

1 reference

1 reference

1 reference

Jyh-Hong Lee

3

0 references

Hsin-Hui Yu

Hsin-Hui Yu

2

0 references

Li-Chieh Wang

Li-Chieh Wang

4

0 references

Yu-Tsan Lin

Yu-Tsan Lin

5

0 references

Yao-Hsu Yang

Yao-Hsu Yang

6

0 references

Bor-Luen Chiang

Bor-Luen Chiang

7

0 references

author name string

Cheng-I Lin

1

1 reference

26 July 2017

22 May 2012

1 reference

26 July 2017

Clinical Rheumatology

1 reference

26 July 2017

31

1 reference

26 July 2017

8

1 reference

26 July 2017

1223-1230

1 reference

Autoimmune-associated hemophagocytic syndrome

26 July 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Macrophage activation syndrome in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Proposed disease activity criteria for mixed connective tissue disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

A case of mixed connective tissue disease successfully treated for hemophagocytic syndrome with intermittent intravenous injection of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Safety of intravenous immunoglobulin (IVIG) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-012-1998-0

Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine

21 January 2018

1 reference

12 December 2020

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

1 reference

12 December 2020

Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.

1 reference

12 December 2020

Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection

1 reference

12 December 2020

Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan

1 reference

12 December 2020

RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study

1 reference

12 December 2020

Kawasaki disease followed by haemophagocytic syndrome.

1 reference

12 December 2020

Macrophage activation syndrome--what's in a name!

1 reference

12 December 2020

Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis

1 reference

12 December 2020

Macrophage activation syndrome: experience from a tertiary referral centre.

1 reference

12 December 2020

Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases

1 reference

12 December 2020

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis

1 reference

12 December 2020

Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids

1 reference

12 December 2020

Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis

1 reference

12 December 2020

Systemic lupus erythematosus disease activity index 2000

1 reference

12 December 2020

Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.

1 reference

12 December 2020

Macrophage activation syndrome as an early presentation of Lupus

1 reference

12 December 2020

Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases.

1 reference

12 December 2020

Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation

1 reference

12 December 2020

10.1007/S10067-012-1998-0

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

22615046